Kelli Greene

4.4k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Kelli Greene is a scholar working on Virology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kelli Greene has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 9 papers in Infectious Diseases and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kelli Greene's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Kelli Greene is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Kelli Greene collaborates with scholars based in United States, South Africa and United Kingdom. Kelli Greene's co-authors include David C. Montefiori, John R. Mascola, Miroslawa Bilska, Hongmei Gao, Ming Li, Feng Gao, Peter B. Gilbert, Leonidas Stamatatos, Jesus F. Salazar-Gonzalez and Xiping Wei and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Kelli Greene

16 papers receiving 1.7k citations

Hit Papers

Human Immunodeficiency Virus Type 1envClones from Acute a... 2005 2026 2012 2019 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelli Greene United States 11 1.5k 799 672 391 390 17 1.7k
Blake Wood United States 8 1.3k 0.9× 773 1.0× 521 0.8× 322 0.8× 322 0.8× 11 1.4k
Stephen D. Schmidt United States 25 1.8k 1.2× 1.1k 1.4× 734 1.1× 619 1.6× 542 1.4× 45 2.2k
Pavel Pugach United States 19 1.6k 1.1× 721 0.9× 829 1.2× 352 0.9× 546 1.4× 23 1.8k
Louise Scharf United States 16 1.3k 0.8× 1.2k 1.5× 433 0.6× 615 1.6× 586 1.5× 19 2.1k
Miroslawa Bilska United States 15 1.9k 1.2× 1.0k 1.3× 810 1.2× 298 0.8× 465 1.2× 19 2.1k
Constantinos Kurt Wibmer South Africa 12 923 0.6× 593 0.7× 972 1.4× 296 0.8× 460 1.2× 17 1.7k
Phillipe N. Nyambi United States 29 1.9k 1.3× 808 1.0× 1.2k 1.7× 371 0.9× 401 1.0× 78 2.3k
Ronald Derking Netherlands 10 1.5k 1.0× 687 0.9× 463 0.7× 661 1.7× 669 1.7× 13 1.7k
Javier Guenaga United States 21 1.3k 0.9× 741 0.9× 416 0.6× 546 1.4× 745 1.9× 40 1.7k
Mattia Bonsignori United States 21 1.1k 0.7× 844 1.1× 348 0.5× 352 0.9× 389 1.0× 38 1.4k

Countries citing papers authored by Kelli Greene

Since Specialization
Citations

This map shows the geographic impact of Kelli Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli Greene more than expected).

Fields of papers citing papers by Kelli Greene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelli Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli Greene. The network helps show where Kelli Greene may publish in the future.

Co-authorship network of co-authors of Kelli Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Kelli Greene. A scholar is included among the top collaborators of Kelli Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelli Greene. Kelli Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cheng, Hao, Karen Dowell, Chris Bailey‐Kellogg, et al.. (2021). Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features. Retrovirology. 18(1). 35–35. 9 indexed citations
2.
Mielke, Dieter, Sherry Stanfield-Oakley, Bhavesh Borate, et al.. (2021). Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies. Journal of Virology. 96(2). e0164321–e0164321. 6 indexed citations
3.
Seaman, Michael S., Miroslawa Bilska, Fadi Ghantous, et al.. (2020). Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs. Journal of Immunological Methods. 479. 112736–112736. 8 indexed citations
4.
Gao, Hongmei, Tanmoy Bhattacharya, Myron S. Cohen, et al.. (2020). Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies. UNC Libraries.
5.
LaBranche, Celia C., Andrew T. McGuire, Matthew D. Gray, et al.. (2018). HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathogens. 14(11). e1007431–e1007431. 22 indexed citations
6.
Hu, Xintao, Yuanyuan Hu, Chunhong Zhao, et al.. (2017). Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy. Scientific Reports. 7(1). 46308–46308. 4 indexed citations
7.
Hraber, Peter, Cecilia Rademeyer, Carolyn Williamson, et al.. (2017). Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments. Journal of Virology. 91(19). 20 indexed citations
8.
Huang, Yunda, Guido Ferrari, Galit Alter, et al.. (2016). Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects. The Journal of Immunology. 197(12). 4603–4612. 36 indexed citations
9.
Kong, Rui, Mark K. Louder, Kshitij Wagh, et al.. (2014). Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes. Journal of Virology. 89(5). 2659–2671. 94 indexed citations
10.
Sarzotti‐Kelsoe, Marcella, Robert T. Bailer, Esra Abacı Türk, et al.. (2013). Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. Journal of Immunological Methods. 409. 131–146. 290 indexed citations
11.
deCamp, Allan C., Peter Hraber, Robert T. Bailer, et al.. (2013). Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies. Journal of Virology. 88(5). 2489–2507. 192 indexed citations
12.
Ozaki, Daniel A., Hongmei Gao, Christopher A. Todd, et al.. (2012). International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials. PLoS ONE. 7(1). e30963–e30963. 31 indexed citations
13.
Hu, Xintao, Kunxue Hong, Chunhong Zhao, et al.. (2012). Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B′-infected former plasma donors from China naïve to antiretroviral therapy. Journal of General Virology. 93(10). 2267–2278. 17 indexed citations
14.
Nelson, Elizabeth, Josh Eckels, Sarah Ramsay, et al.. (2011). LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays. BMC Immunology. 12(1). 33–33. 10 indexed citations
15.
Todd, Christopher A., Kelli Greene, Xuesong Yu, et al.. (2011). Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells. Journal of Immunological Methods. 375(1-2). 57–67. 50 indexed citations
16.
Gnanakaran, S., Marcus Daniels, Tanmoy Bhattacharya, et al.. (2010). Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies. PLoS Computational Biology. 6(10). e1000955–e1000955. 59 indexed citations
17.
Li, Ming, Feng Gao, John R. Mascola, et al.. (2005). Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies. Journal of Virology. 79(16). 10108–10125. 845 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026